Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Akkerhuis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Circulation|November 16, 1999
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary interventionE Boersma, K M Akkerhuis, P Théroux, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 21, 2007
[Congenital long QT-syndrome: the cause of recurrent syncope and sudden death at a young age]J M Akkerhuis, H F Baars, C L M Marcelis, et al.
European Heart Journal|October 18, 2001
Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patientsK M Akkerhuis, P A Klootwijk, W Lindeboom, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 17, 1995
[Improved diabetes control through strict observance of the standard 'Type II Diabetes Mellitus' from the Dutch College of Family Physicians]M L Jacobs, K M Akkerhuis, M J van Dijk, et al.
Journal of Electrocardiology|May 20, 2000
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyK M Akkerhuis, A C Maas, P A Klootwijk, et al.
Heart (British Cardiac Society)|May 12, 2011
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndromeR M Oemrawsingh, T Lenderink, K M Akkerhuis, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unitJ A Lipton, R J Barendse, R T Van Domburg, et al.
International Journal of Cardiology|June 16, 2024
Temporal evolution of anxiety and depression in chronic heart failure and its association with clinical outcomeS Abou Kamar, B Oostdijk, K Andrzejczyk, et al.
JAMA|July 4, 2001
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary interventionK M Akkerhuis, J W Deckers, A M Lincoff, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 26, 2018
e-Transmission of ECGs for expert consultation results in improved triage and treatment of patients with acute ischaemic chest pain by ambulance paramedicsS S Anroedh, I Kardys, K M Akkerhuis, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Circulation|November 16, 1999
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary interventionE Boersma, K M Akkerhuis, P Théroux, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 21, 2007
[Congenital long QT-syndrome: the cause of recurrent syncope and sudden death at a young age]J M Akkerhuis, H F Baars, C L M Marcelis, et al.
European Heart Journal|October 18, 2001
Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patientsK M Akkerhuis, P A Klootwijk, W Lindeboom, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 17, 1995
[Improved diabetes control through strict observance of the standard 'Type II Diabetes Mellitus' from the Dutch College of Family Physicians]M L Jacobs, K M Akkerhuis, M J van Dijk, et al.
Journal of Electrocardiology|May 20, 2000
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyK M Akkerhuis, A C Maas, P A Klootwijk, et al.
Heart (British Cardiac Society)|May 12, 2011
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndromeR M Oemrawsingh, T Lenderink, K M Akkerhuis, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unitJ A Lipton, R J Barendse, R T Van Domburg, et al.
International Journal of Cardiology|June 16, 2024
Temporal evolution of anxiety and depression in chronic heart failure and its association with clinical outcomeS Abou Kamar, B Oostdijk, K Andrzejczyk, et al.
JAMA|July 4, 2001
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary interventionK M Akkerhuis, J W Deckers, A M Lincoff, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 26, 2018
e-Transmission of ECGs for expert consultation results in improved triage and treatment of patients with acute ischaemic chest pain by ambulance paramedicsS S Anroedh, I Kardys, K M Akkerhuis, et al.
Pageof 3